Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
uniQure N.V. (QURE)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
10/05/2023
8-K
Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs:
"
uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs
"
08/01/2023
8-K
Quarterly results
06/16/2023
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
05/16/2023
8-K
Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
"
uniQure Announces Sale of Royalty Interest in HEMGENIX for Up To $400 Million
"
05/09/2023
8-K
Quarterly results
Docs:
"
uniQure Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
"
04/05/2023
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/27/2023
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
"
uniQure Announces 2022 Financial Results and Highlights Recent Company Progress
"
01/31/2023
8-K
Other Events, Financial Statements and Exhibits Interactive Data
Docs:
"
uniQure and Apic Bio enter into global licensing agreement for APB-102, a clinical stage gene therapy for patients with ALS caused by mutations in SOD1
"
12/16/2022
8-K
Quarterly results
11/28/2022
8-K
Quarterly results
11/23/2022
8-K
Quarterly results
11/02/2022
8-K
Quarterly results
08/08/2022
8-K
Quarterly results
06/15/2022
8-K
Quarterly results
05/24/2022
8-K
Quarterly results
05/02/2022
8-K
Quarterly results
03/22/2022
8-K
Other Events, Financial Statements and Exhibits Interactive Data
Docs:
"
uniQure Announces Completion of Patient Enrollment in the First Two Cohorts of its Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’ s Disease
"
02/25/2022
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
"
uniQure Announces 2021 Financial Results and Highlights Recent Company Progress
"
02/08/2022
8-K
Quarterly results
02/04/2022
8-K
Quarterly results
12/28/2021
8-K
Entry into a Material Definitive Agreement Interactive Data
12/17/2021
8-K
Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
"
uniQure Announces Clinical Update on First Patients in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
"
12/13/2021
8-K
Quarterly results
10/25/2021
8-K
Quarterly results
Docs:
"
uniQure Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress
"
10/21/2021
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
07/30/2021
8-K
Quarterly results
07/27/2021
8-K
Quarterly results
Docs:
"
uniQure Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress
"
06/23/2021
8-K
Quarterly results
06/21/2021
8-K
Quarterly results
05/21/2021
8-K
Quarterly results
05/10/2021
8-K
Quarterly results
05/07/2021
8-K
Quarterly results
04/26/2021
8-K
Quarterly results
04/22/2021
8-K
Quarterly results
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy